Category Specific RSS

Zoono Group (ASX: ZNO)

Zoono Group Ltd. is a pharmaceutical and biotechnology company. The company is headquartered in Sydney, New South Wales. The firm is focused on developing, manufacturing and distributing of scientifically validated antimicrobial solutions. The firm’s products are based on the Zoono molecule, which is a water-bases antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mold. The firm’s products include sprays, sanitizers, wipes and foams suited for skin care, surface sanitizers, business, and mold remediation treatments. Its sanitizer products include surface sanitizer and hand sanitizer in the form of refill sachets, wall dispenser units, bulk carton, shield surface sanitizers.

Here are the latest articles on Zoono Group (ASX: ZNO)

Zoono and OSY team up to tackle food waste in exclusive agreement

Despite global efforts, food waste remains a challenging problem to solve. Each year, 1.3 billion tons of food is wasted due to poor handling, costing the global economy $1.5 trillion. This waste contributes 6-8% of annual greenhouse gas emissions and, what’s more, if saved, it could have fed about 1.26 billion people. No doubt, food

Apiam partner receives approval to launch Xtend 21 Antimicrobial Surface Protectant across US veterinary markets

The US Environmental Protection Agency has granted regulatory label approval for the commercialisation of Xtend 21®– an innovative product that has been demonstrated by university studies to enhance long term antimicrobial surface protection. The pathway of Xtend 21® for the US market first commenced in March 2020 when Apiam Animal Health (ASX: AHX) was appointed the exclusive

The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?

Who said capitalism was dead in the new world order of prolific government handouts? The profit motive is at least alive and kicking in the sexed-up sanitiser sector, as both new and established participants grab on to what’s hopefully a once-in-a-lifetime opportunity. For consumers, it’s a case of “you can’t be serious” as they scour

Zoono successfully tests against coronavirus COVID-19, shares skyrocket

Biotech company Zoono Group (ASX: ZNO) has reported that its lab tests against COVID-19 have shown their hand sanitiser product to have more than 99.99% efficacy in deactivating the coronavirus pathogens.  Conducted under strict European testing standards, the tests conducted identified Zoono’s Z-71 Microbe Shield hand sanitiser to be effective against a variety of pathogens

Zoono secures Chinese distributor after impressive African swine fever trials

With China having lost more than 100 million pigs due to the recent outbreak of African swine fever in the mainland, attention has been thrust upon preventative measures, leading a Chinese Group to engage chemical company Zoono (ASX: ZNO) for a 10-year distribution arrangement.  The Chinese Group will use the Zoono China brand to sell